Wendel U - Search Results

1

Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.

Schönberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U. Schönberger S, et al. Among authors: wendel u. Mol Genet Metab. 2004 May;82(1):69-75. doi: 10.1016/j.ymgme.2004.01.016. Mol Genet Metab. 2004. PMID: 15110325

2

Diurnal changes in plasma amino acids in maple syrup urine disease.

Schwahn B, Wendel U, Schadewaldt P, Falkenberg N, Mönch E. Schwahn B, et al. Among authors: wendel u. Acta Paediatr. 1998 Dec;87(12):1245-6. doi: 10.1080/080352598750030915. Acta Paediatr. 1998. PMID: 9894823

3

Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.

Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U. Heldt K, et al. Among authors: wendel u. Mol Genet Metab. 2005 Apr;84(4):313-6. doi: 10.1016/j.ymgme.2004.11.010. Epub 2005 Jan 24. Mol Genet Metab. 2005. PMID: 15781191

4

Social outcome in adults with maple syrup urine disease (MSUD).

Simon E, Schwarz M, Wendel U. Simon E, et al. Among authors: wendel u. J Inherit Metab Dis. 2007 Apr;30(2):264. doi: 10.1007/s10545-007-0475-4. Epub 2007 Feb 19. J Inherit Metab Dis. 2007. PMID: 17310329

5

Disturbance of cultured rat neuronal network activity depends on concentration and ratio of leucine and alpha-ketoisocaproate: implication for acute encephalopathy of maple syrup urine disease.

Görtz P, Köller H, Schwahn B, Wendel U, Siebler M. Görtz P, et al. Among authors: wendel u. Pediatr Res. 2003 Feb;53(2):320-4. doi: 10.1203/01.PDR.0000047521.50656.16. Pediatr Res. 2003. PMID: 12538793

6

Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.

Däublin G, Schwahn B, Wendel U. Däublin G, et al. Among authors: wendel u. Eur J Pediatr. 2002 Oct;161 Suppl 1:S40-5. doi: 10.1007/s00431-002-1001-1. Epub 2002 Aug 22. Eur J Pediatr. 2002. PMID: 12373569

7

Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.

Schwahn B, Rauch F, Wendel U, Schönau E. Schwahn B, et al. Among authors: wendel u. J Pediatr. 2002 Sep;141(3):350-6. doi: 10.1067/mpd.2002.126456. J Pediatr. 2002. PMID: 12219054

8

Glycogen storage disease type Ib without hypoglycemia.

Kovacevic A, Ehrlich R, Mayatepek E, Wendel U, Schwahn B. Kovacevic A, et al. Among authors: wendel u. Mol Genet Metab. 2007 Mar;90(3):349-50. doi: 10.1016/j.ymgme.2006.11.002. Epub 2006 Dec 14. Mol Genet Metab. 2007. PMID: 17174133 No abstract available.

9

Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency.

Schwahn BC, Wendel U, Lussier-Cacan S, Mar MH, Zeisel SH, Leclerc D, Castro C, Garrow TA, Rozen R. Schwahn BC, et al. Among authors: wendel u. Metabolism. 2004 May;53(5):594-9. doi: 10.1016/j.metabol.2003.10.033. Metabolism. 2004. PMID: 15131763

10

Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.

Simon E, Wendel U, Schadewaldt P. Simon E, et al. Among authors: wendel u. Turk J Pediatr. 2005 Jan-Mar;47(1):8-13. Turk J Pediatr. 2005. PMID: 15884622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters